Adults with type 2 diabetes may be more likely to report smell and taste disturbances if they were prescribed a GLP-1 receptor agonist, according to data published in JAMA Otolaryngology – Head & Neck Surgery.In an analysis of data from the TriNetX electronic health records database, researchers compared smell and taste disturbances among adults with type 2 diabetes who were…
Source: Healio News
